rs8079610
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_213607.3(CCDC103):c.277-63C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,600,552 control chromosomes in the GnomAD database, including 59,590 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 5277 hom., cov: 32)
Exomes 𝑓: 0.27 ( 54313 hom. )
Consequence
CCDC103
NM_213607.3 intron
NM_213607.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.50
Genes affected
CCDC103 (HGNC:32700): (coiled-coil domain containing 103) Enables protein homodimerization activity. Involved in axonemal dynein complex assembly; cilium movement; and determination of left/right symmetry. Predicted to be located in axoneme. Predicted to be part of outer dynein arm. Implicated in primary ciliary dyskinesia 17. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 17-44902302-C-A is Benign according to our data. Variant chr17-44902302-C-A is described in ClinVar as [Benign]. Clinvar id is 402498.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-44902302-C-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.277 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC103 | ENST00000417826.3 | c.277-63C>A | intron_variant | 1 | NM_213607.3 | ENSP00000391692.2 | ||||
CCDC103 | ENST00000410006.6 | c.277-63C>A | intron_variant | 2 | ENSP00000387252.1 | |||||
CCDC103 | ENST00000357776.6 | c.277-63C>A | intron_variant | 2 | ENSP00000350420.2 | |||||
CCDC103 | ENST00000410027.5 | c.277-16C>A | intron_variant | 4 | ENSP00000386640.1 |
Frequencies
GnomAD3 genomes AF: 0.261 AC: 39732AN: 151988Hom.: 5272 Cov.: 32
GnomAD3 genomes
AF:
AC:
39732
AN:
151988
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.268 AC: 66716AN: 248638Hom.: 9201 AF XY: 0.269 AC XY: 36230AN XY: 134698
GnomAD3 exomes
AF:
AC:
66716
AN:
248638
Hom.:
AF XY:
AC XY:
36230
AN XY:
134698
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.273 AC: 395513AN: 1448446Hom.: 54313 Cov.: 29 AF XY: 0.274 AC XY: 197545AN XY: 721464
GnomAD4 exome
AF:
AC:
395513
AN:
1448446
Hom.:
Cov.:
29
AF XY:
AC XY:
197545
AN XY:
721464
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.261 AC: 39759AN: 152106Hom.: 5277 Cov.: 32 AF XY: 0.261 AC XY: 19405AN XY: 74358
GnomAD4 genome
AF:
AC:
39759
AN:
152106
Hom.:
Cov.:
32
AF XY:
AC XY:
19405
AN XY:
74358
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
791
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at